SCN1A and encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy: A similar SpCas9-VP64 dual AAV vector system was used in two recent studies to activate the Kcn1 or the Scn1a gene to treat the respective mouse model for epilepsy or Dravet syndrome [16, 17].